Acute Ischemic Stroke Intervention.

Link to article at PubMed

Related Articles

Acute Ischemic Stroke Intervention.

J Am Coll Cardiol. 2016 Jun 7;67(22):2631-44

Authors: Khandelwal P, Yavagal DR, Sacco RL

Acute ischemic stroke (AIS) is the leading cause of disability worldwide and among the leading causes of mortality. Although intravenous tissue plasminogen activator (IV-rtPA) was approved nearly 2 decades ago for treatment of AIS, only a minority of patients receive it due to a narrow time window for administration and several contraindications to its use. Endovascular approaches to recanalization in AIS developed in the 1980s, and recently, 5 major randomized trials showed an overwhelming superior benefit of combining endovascular mechanical thrombectomy with IV-rtPA over IV-rtPA alone. In this paper, we discuss the evolution of catheter-based treatment from first-generation thrombectomy devices to the game-changing stent retrievers, results from recent trials, and the evolving stroke systems of care to provide timely access to acute stroke intervention to patients in the United States.

PMID: 27256835 [PubMed - in process]

Leave a Reply

Your email address will not be published. Required fields are marked *